GlassScriptPhysician profile
Gretchen A Crews
NPI 1689026692
$6,552.53
in general payments reported to CMS, 2019-2025
14 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $978 · 2022: $1,314 · 2023: $1,783 · 2024: $1,321 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,124 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,124.08 |
| Education | $136.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $2,422.74 | 2021-2025 | Aristada, Aristada Initio, Vivitrol |
| Janssen Pharmaceuticals, INC | $876.15 | 2021-2025 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $654.81 | 2021-2024 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $572.50 | 2021-2025 | Uzedy, Austedo |
| Vanda Pharmaceuticals INC. | $405.77 | 2023-2025 | Fanapt, Hetlioz |
| Abbvie INC. | $399.10 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $284.57 | 2024-2025 | Ingrezza |
| Indivior INC. | $282.75 | 2022-2025 | Sublocade, Perseris |
| Otsuka America Pharmaceutical, INC. | $245.70 | 2021-2025 | Abilify Asimtufii, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $188.97 | 2024-2025 | Cobenfy |
| Braeburn INC. | $86.36 | 2025 | Brixadi |
| Tempus Ai, INC | $58.20 | 2024 | |
| Luye Pharma (USA) LTD. | $40.57 | 2025 | Erzofri Extended-Release |
| Axsome Therapeutics, INC. | $34.34 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Crews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.